Sutro Biopharma (STRO) — Financial Flexibility Index
Sutro Biopharma (STRO) has a Financial Flexibility Index of -0.13x as of September 2025. Free cash flow of $-37.94 Million (operating CF $-38.19 Million minus capex $251.00K) represents 0% of total liabilities ($296.93 Million). Also explore how fast is Sutro Biopharma growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sutro Biopharma Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Sutro Biopharma across 9 annual periods. Check Sutro Biopharma (STRO) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sutro Biopharma (2016–2024)
Year-by-year free cash flow to debt coverage for Sutro Biopharma. For the full company profile including market capitalisation, see STRO market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | $-188.44 Million | $-191.54 Million | $342.61 Million | ▼ -64.6% |
| 2023 | -0.33x | $-107.30 Million | $-111.62 Million | $321.09 Million | ▼ -656.3% |
| 2022 | 0.06x | $11.41 Million | $3.55 Million | $189.90 Million | ▲ +108.0% |
| 2021 | -0.75x | $-66.36 Million | $-81.68 Million | $88.84 Million | ▲ +23.6% |
| 2020 | -0.98x | $-60.67 Million | $-67.80 Million | $62.06 Million | ▲ +6.9% |
| 2019 | -1.05x | $-61.54 Million | $-65.02 Million | $58.58 Million | ▼ -775.8% |
| 2018 | 0.16x | $14.24 Million | $12.68 Million | $91.60 Million | ▲ +169.0% |
| 2017 | -0.23x | $-33.76 Million | $-37.07 Million | $149.77 Million | ▼ -312.2% |
| 2016 | -0.05x | $-8.76 Million | $-13.15 Million | $160.18 Million | — |